Search Clinical Trials
Home >  Clinical Trials & Research >  Search Clinical Trials
Print

Clinical Trials & Research

Search Clinical Trials

Clinical Trials

New Search
Title   A Phase 1/2 Study of HDAC Inhibitor, Mocetinostat, in Combination With PD-L1 Inhibitor, Durvalumab, in Advanced or Metastatic Solid Tumors and Non-Small Cell Lung Cancer
Disease/Condition   Lung Cancer,Solid Tumor
Description  

Click here for more information

Eligibility Criteria   Ages Eligible for Study: 18 Years and older (Adult, Senior) Genders Eligible for Study: Both Accepts Healthy Volunteers: No Click here for eligibility requirements
Principal Investigator   Missak Haigentz, MD
Contact Name   Karen Fehn, RN
Phone   (718) 405-8446
Contact Email   CPDMUtrialinfo@montefiore.org
Protocol Number   IRB# 16-06-41-01
Inclusion/Notes   This information was obtained from ClinicalTrials.gov.
Status   Enrolling
Adult Clinical Trial   Yes
Pediatric Clinical Trial   No